Investor
The deal is expected to close in the second half of 2021 and be worth roughly $4.2 billion.
With this raise, in addition to Nayya’s Series A round from earlier this year, the company has raised nearly $50 million to date.
Frost & Sullivan says the recent shift in attention away from primarily focusing on reproductive-age issues to untapped market areas will be a key factor to the sector’s growth.
From unlocking new patient data to looking beyond the apps for digital care, how the digital infrastructure needs to change for the future.
The Canadian Trade Commission's accelerator angles to help young companies get their start in the U.S. and other nations.
The company plans to use the new funds to expand its therapeutics beyond ADHD.
The platform can give users resources about treatment, educational plans and coping with ADHD.
The company is using the funds to expand into new care areas including sleep, hypertension and diabetes.
The acquisition will give AMN Healthcare a foothold in the virtual home health and outpatient care space.
Also: MindPortal lands $5 million for its wearable noninvasive brain-computer device and Docbot raises $4 million for its GI-disease-detecting software.